Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020)
Neurocrine Biosciences (NBIX) posted quarterly Change in Working Capital of $4.1 million for Q1 2020, up 224.24% year-over-year from $1.3 million in Q2 2019, and up 224.24% on a QoQ basis from -$3.3 million in Q1 2019.
Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020) Analysis & Trends
Neurocrine Biosciences has reported Change in Working Capital for 2 years, with the latest figure at $4.1 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -164.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2019 | -3.30 Mn |
| Mar 31, 2019 | -3.30 Mn |